{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:59:35Z","timestamp":1780873175197,"version":"3.54.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Major Scientific Research Projects of Wuxi City","award":["NO:Z202325"],"award-info":[{"award-number":["NO:Z202325"]}]},{"name":"\u201cTaihu Light\u201d Science and Technology Innovation Project (Basic Research) of Wuxi","award":["No. K20221021"],"award-info":[{"award-number":["No. K20221021"]}]},{"name":"Wuxi Municipal Health Commission Youth Science Fund","award":["No. Q202138"],"award-info":[{"award-number":["No. Q202138"]}]},{"name":"General projects of Wuxi Medical Center, Nanjing Medical University","award":["No. WMCG202357"],"award-info":[{"award-number":["No. WMCG202357"]}]},{"name":"Nanjing Medical University Science and Technology Development Fund-General Project","award":["No. NMUB20220173"],"award-info":[{"award-number":["No. NMUB20220173"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48493-4","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:13:29Z","timestamp":1776273209000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning prediction of postoperative recurrence in bladder cancer using clinical and laboratory indicators"],"prefix":"10.1038","volume":"16","author":[{"given":"Lanyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninghan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianfeng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"16","key":"48493_CR1","doi-asserted-by":"publisher","first-page":"e70020","DOI":"10.1002\/cncr.70020","volume":"131","author":"AB Apolo","year":"2025","unstructured":"Apolo, A. B. et al. Top Advances of the Year: Bladder Cancer. Cancer 131 (16), e70020. https:\/\/doi.org\/10.1002\/cncr.70020 (2025).","journal-title":"Cancer"},{"issue":"6","key":"48493_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41585-024-00963-y","volume":"22","author":"M Leyderman","year":"2025","unstructured":"Leyderman, M. et al. Metastasis Development in Non-Muscle-Invasive Bladder Cancer. Nat. Rev. Urol. 22 (6), 375\u2013386. https:\/\/doi.org\/10.1038\/s41585-024-00963-y (2025). Epub 20241120.","journal-title":"Nat. Rev. Urol."},{"issue":"5","key":"48493_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.urolonc.2024.12.264","volume":"43","author":"S Daneshmand","year":"2025","unstructured":"Daneshmand, S. et al. Development of Tar-200: A Novel Targeted Releasing System Designed to Provide Sustained Delivery of Gemcitabine for Patients with Bladder Cancer. Urol. Oncol. 43 (5), 286\u2013296. https:\/\/doi.org\/10.1016\/j.urolonc.2024.12.264 (2025). Epub 20250115.","journal-title":"Urol. Oncol."},{"key":"48493_CR4","doi-asserted-by":"publisher","unstructured":"Lopez-Beltran, A., Cookson, M. S., Guercio, B. J. & Cheng, L. Advances in Diagnosis and Treatment of Bladder Cancer. Bmj 384:e076743. Epub 20240212. (2024). https:\/\/doi.org\/10.1136\/bmj-2023-076743","DOI":"10.1136\/bmj-2023-076743"},{"issue":"19","key":"48493_CR5","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis, A. T., Lec, P. M., Chamie, K. & Mshs, M. D. Bladder Cancer: A Review. Jama 324 (19), 1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598 (2020).","journal-title":"Jama"},{"issue":"2","key":"48493_CR6","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00345-022-04253-3","volume":"41","author":"Y Soorojebally","year":"2023","unstructured":"Soorojebally, Y. et al. Urinary Biomarkers for Bladder Cancer Diagnosis and Nmibc Follow-Up: A Systematic Review. World J. Urol. 41 (2), 345\u2013359. https:\/\/doi.org\/10.1007\/s00345-022-04253-3 (2023). Epub 20230102.","journal-title":"World J. Urol."},{"issue":"1","key":"48493_CR7","doi-asserted-by":"publisher","first-page":"e05256","DOI":"10.1002\/ccr3.5256","volume":"10","author":"V Bilim","year":"2022","unstructured":"Bilim, V. & Hoshi, S. Prostatic Urethra Recurrence after Transurethral Resection of Bladder Tumor (Turbt) for Non-Muscle-Invasive Bladder Cancer (Nmibc). Clin. Case Rep. 10 (1), e05256. https:\/\/doi.org\/10.1002\/ccr3.5256 (2022). Epub 20220108.","journal-title":"Clin. Case Rep."},{"key":"48493_CR8","doi-asserted-by":"publisher","unstructured":"Wang, Q. et al. The Predictive Value of Urinary Twist1 Methylation and Vi-Rads Score for Residual Tumor before Repeat Transurethral Resection of Bladder Tumor in Nmibc Patients. Urol. Int. 1\u201311. https:\/\/doi.org\/10.1159\/000546718 (2025). Epub 20250606.","DOI":"10.1159\/000546718"},{"issue":"5","key":"48493_CR9","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.31557\/apjcp.2025.26.5.1767","volume":"26","author":"A Kassem","year":"2025","unstructured":"Kassem, A., Assem, A., Sharawy, A., Ezz El Deen, M. & Emran, A. The Effect of Surgeon Experience on the Recurrence of Non-Muscle Invasive Bladder Cancer (Nmibc), Following Transurethral Resection of the Bladder Tumor (Turbt): A Double Blinded Prospective Randomized Study. Asian Pac. J. Cancer Prev. 26 (5), 1767\u20131771. https:\/\/doi.org\/10.31557\/apjcp.2025.26.5.1767 (2025). Epub 20250501.","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"1","key":"48493_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.21037\/tau.2019.01.15","volume":"8","author":"S Zamboni","year":"2019","unstructured":"Zamboni, S. et al. Prediction Tools in Non-Muscle Invasive Bladder Cancer. Transl Androl. Urol. 8 (1), 39\u201345. https:\/\/doi.org\/10.21037\/tau.2019.01.15 (2019).","journal-title":"Transl Androl. Urol."},{"issue":"4","key":"48493_CR11","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4103\/0970-1591.166445","volume":"31","author":"S Isharwal","year":"2015","unstructured":"Isharwal, S. & Konety, B. Non-Muscle Invasive Bladder Cancer Risk Stratification. Indian J. Urol. 31 (4), 289\u2013296. https:\/\/doi.org\/10.4103\/0970-1591.166445 (2015).","journal-title":"Indian J. Urol."},{"issue":"2","key":"48493_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1167\/tvst.9.2.14","volume":"9","author":"RY Choi","year":"2020","unstructured":"Choi, R. Y., Coyner, A. S., Kalpathy-Cramer, J., Chiang, M. F. & Campbell, J. P. Introduction to Machine Learning, Neural Networks, and Deep Learning. Transl Vis. Sci. Technol. 9 (2), 14. https:\/\/doi.org\/10.1167\/tvst.9.2.14 (2020). Epub 20200227.","journal-title":"Transl Vis. Sci. Technol."},{"issue":"3","key":"48493_CR13","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","volume":"25","author":"R Gupta","year":"2021","unstructured":"Gupta, R. et al. Artificial Intelligence to Deep Learning: Machine Intelligence Approach for Drug Discovery. Mol. Divers. 25 (3), 1315\u20131360. https:\/\/doi.org\/10.1007\/s11030-021-10217-3 (2021). Epub 20210412.","journal-title":"Mol. Divers."},{"key":"48493_CR14","doi-asserted-by":"publisher","unstructured":"Beijert, I. J. et al. Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-Muscle-Invasive Spectrum. Eur. Urol. Oncol. 6 (2), 214\u2013221. https:\/\/doi.org\/10.1016\/j.euo.2023.01.004 (2023). Epub 20230118.","DOI":"10.1016\/j.euo.2023.01.004"},{"issue":"4","key":"48493_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11255-023-03867-9","volume":"56","author":"IJ Beijert","year":"2024","unstructured":"Beijert, I. J. et al. Second Turb, Restaging Turb or Repeat Turb in Primary T1 Non-Muscle Invasive Bladder Cancer: Impact on Prognosis? Int. Urol. Nephrol. 56 (4), 1323\u20131333. https:\/\/doi.org\/10.1007\/s11255-023-03867-9 (2024). Epub 20231119.","journal-title":"Int. Urol. Nephrol."},{"issue":"2","key":"48493_CR16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/bju.15984","volume":"132","author":"F Claps","year":"2023","unstructured":"Claps, F. et al. Prognostic Impact of Variant Histologies in Urothelial Bladder Cancer Treated with Radical Cystectomy. BJU Int. 132 (2), 170\u2013180. https:\/\/doi.org\/10.1111\/bju.15984 (2023). Epub 20230220.","journal-title":"BJU Int."},{"issue":"3","key":"48493_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.urolonc.2024.11.015","volume":"43","author":"R Contieri","year":"2025","unstructured":"Contieri, R. et al. Impact of Smoking Exposure on Disease Progression in High Risk and Very High-Risk Nonmuscle Invasive Bladder Cancer Patients Undergoing Bcg Therapy. Urol. Oncol. 43 (3), 189. https:\/\/doi.org\/10.1016\/j.urolonc.2024.11.015 (2025). e1-.e8. Epub 20241212.","journal-title":"Urol. Oncol."},{"issue":"5","key":"48493_CR18","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/bju.16828","volume":"136","author":"M Ferro","year":"2025","unstructured":"Ferro, M. et al. Enhanced Prognostic Value of Four-Tier Hybrid Grading System in Ta Non-Muscle-Invasive Bladder Cancer. BJU Int. 136 (5), 882\u2013890. https:\/\/doi.org\/10.1111\/bju.16828 (2025). Epub 20250625.","journal-title":"BJU Int."},{"key":"48493_CR19","doi-asserted-by":"publisher","unstructured":"Heidegger, I., Re, N., Mehra, E. S., Antonarakis, S. H. & Park Et Al. Patient-Reported Outcomes in Keylynk-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide. Eururol Oncol. In Press. Https:\/\/Doi.Org\/10.1016\/J.Euo.2025.04.018. Eur Urol Oncol 8(6):1707. Epub 20251021. (2025). https:\/\/doi.org\/10.1016\/j.euo.2025.07.017","DOI":"10.1016\/j.euo.2025.07.017"},{"issue":"4","key":"48493_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","volume":"79","author":"RJ Sylvester","year":"2021","unstructured":"Sylvester, R. J. et al. European Association of Urology (Eau) Prognostic Factor Risk Groups for Non-Muscle-Invasive Bladder Cancer (Nmibc) Incorporating the Who 2004\/2016 and Who 1973 Classification Systems for Grade: An Update from the Eau Nmibc Guidelines Panel. Eur. Urol. 79 (4), 480\u2013488. https:\/\/doi.org\/10.1016\/j.eururo.2020.12.033 (2021). Epub 20210106.","journal-title":"Eur. Urol."},{"issue":"11","key":"48493_CR21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11906-022-01212-6","volume":"24","author":"GFS Silva","year":"2022","unstructured":"Silva, G. F. S., Fagundes, T. P., Teixeira, B. C. & Chiavegatto Filho, A. D. P. Machine Learning for Hypertension Prediction: A Systematic Review. Curr. Hypertens. Rep. 24 (11), 523\u2013533. https:\/\/doi.org\/10.1007\/s11906-022-01212-6 (2022). Epub 20220622.","journal-title":"Curr. Hypertens. Rep."},{"issue":"1","key":"48493_CR22","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s12911-023-02377-z","volume":"23","author":"D Zuo","year":"2023","unstructured":"Zuo, D. et al. Machine Learning-Based Models for the Prediction of Breast Cancer Recurrence Risk. BMC Med. Inf. Decis. Mak. 23 (1), 276. https:\/\/doi.org\/10.1186\/s12911-023-02377-z (2023). Epub 20231129.","journal-title":"BMC Med. Inf. Decis. Mak."},{"issue":"1","key":"48493_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41572-021-00254-5","volume":"7","author":"JY Blay","year":"2021","unstructured":"Blay, J. Y., Kang, Y. K., Nishida, T. & von Mehren, M. Gastrointestinal Stromal Tumours. Nat. Rev. Dis. Primers. 7 (1), 22. https:\/\/doi.org\/10.1038\/s41572-021-00254-5 (2021). Epub 20210318.","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"3","key":"48493_CR24","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/s1470-2045(11)70299-6","volume":"13","author":"H Joensuu","year":"2012","unstructured":"Joensuu, H. et al. Risk of Recurrence of Gastrointestinal Stromal Tumour after Surgery: An Analysis of Pooled Population-Based Cohorts. Lancet Oncol. 13 (3), 265\u2013274. https:\/\/doi.org\/10.1016\/s1470-2045(11)70299-6 (2012). Epub 20111206.","journal-title":"Lancet Oncol."},{"issue":"4","key":"48493_CR25","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/path.5902","volume":"257","author":"E Gadaleta","year":"2022","unstructured":"Gadaleta, E., Thorn, G. J., Ross-Adams, H., Jones, L. J. & Chelala, C. Field Cancerization in Breast Cancer. J. Pathol. 257 (4), 561\u2013574. https:\/\/doi.org\/10.1002\/path.5902 (2022). Epub 20220503.","journal-title":"J. Pathol."},{"issue":"3","key":"48493_CR26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.jaad.2020.03.126","volume":"83","author":"TJ Willenbrink","year":"2020","unstructured":"Willenbrink, T. J. et al. Field Cancerization: Definition, Epidemiology, Risk Factors, and Outcomes. J. Am. Acad. Dermatol. 83 (3), 709\u2013717. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.126 (2020). Epub 20200507.","journal-title":"J. Am. Acad. Dermatol."},{"issue":"3","key":"48493_CR27","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.jaad.2020.03.127","volume":"83","author":"CM Cornejo","year":"2020","unstructured":"Cornejo, C. M. et al. Field Cancerization: Treatment. J. Am. Acad. Dermatol. 83 (3), 719\u2013730. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.127 (2020). Epub 20200506.","journal-title":"J. Am. Acad. Dermatol."},{"issue":"4","key":"48493_CR28","first-page":"255","volume":"64","author":"M Brausi","year":"2012","unstructured":"Brausi, M. & Olaru, V. Management of High-Risk Non-Muscle Invasive Bladder Cancer. Minerva Urol. Nefrol. 64 (4), 255\u2013260 (2012).","journal-title":"Minerva Urol. Nefrol"},{"issue":"5","key":"48493_CR29","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","volume":"73","author":"AM Kamat","year":"2018","unstructured":"Kamat, A. M. et al. Predicting Response to Intravesical Bacillus Calmette-Gu\u00e9rin Immunotherapy: Are We There Yet? A Systematic Review. Eur. Urol. 73 (5), 738\u2013748. https:\/\/doi.org\/10.1016\/j.eururo.2017.10.003 (2018). Epub 20171018.","journal-title":"Eur. Urol."},{"issue":"3","key":"48493_CR30","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","volume":"6","author":"V Soukup","year":"2020","unstructured":"Soukup, V. et al. Risk Stratification Tools and Prognostic Models in Non-Muscle-Invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-Muscle-Invasive Bladder Cancer Guidelines Panel. Eur. Urol. Focus. 6 (3), 479\u2013489. https:\/\/doi.org\/10.1016\/j.euf.2018.11.005 (2020). Epub 20181122.","journal-title":"Eur. Urol. Focus"},{"issue":"11","key":"48493_CR31","doi-asserted-by":"publisher","first-page":"6489","DOI":"10.21037\/tcr-24-180","volume":"13","author":"AM Soltani-Tehrani","year":"2024","unstructured":"Soltani-Tehrani, A. M., Kumar, A. & Pohar, K. S. Predicting Response to Bacillus Calmette-Guerin in High-Risk Non-Muscle Invasive Bladder Cancer. Transl Cancer Res. 13 (11), 6489\u20136502. https:\/\/doi.org\/10.21037\/tcr-24-180 (2024). Epub 20240730.","journal-title":"Transl Cancer Res."},{"issue":"2","key":"48493_CR32","doi-asserted-by":"publisher","first-page":"189","DOI":"10.5507\/bp.2013.019","volume":"158","author":"J Chudacek","year":"2014","unstructured":"Chudacek, J. et al. Detection of Minimal Residual Disease in Lung Cancer. Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub. 158 (2), 189\u2013193. https:\/\/doi.org\/10.5507\/bp.2013.019 (2014). Epub 20130402.","journal-title":"Biomed. Pap Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"issue":"6","key":"48493_CR33","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.21037\/tau.2019.09.38","volume":"9","author":"LHC Kim","year":"2020","unstructured":"Kim, L. H. C. & Patel, M. I. Transurethral Resection of Bladder Tumour (Turbt). Transl Androl. Urol. 9 (6), 3056\u20133072. https:\/\/doi.org\/10.21037\/tau.2019.09.38 (2020).","journal-title":"Transl Androl. Urol."},{"issue":"7","key":"48493_CR34","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/bco2.365","volume":"5","author":"H Klempfner","year":"2024","unstructured":"Klempfner, H. & Anderson, P. Comparison of Staging Mri to Re-Resection for Localised Bladder Cancer: Narrative Review. BJUI Compass. 5 (7), 651\u2013661. https:\/\/doi.org\/10.1002\/bco2.365 (2024). Epub 20240424.","journal-title":"BJUI Compass"},{"issue":"2","key":"48493_CR35","doi-asserted-by":"publisher","first-page":"E87","DOI":"10.1111\/j.1464-410X.2012.11650.x","volume":"112","author":"JB Yuan","year":"2013","unstructured":"Yuan, J. B. et al. Laparoscopic Pelvic Lymph Node Dissection System Based on Preoperative Primary Tumour Stage (T Stage) by Computed Tomography in Urothelial Bladder Cancer: Results of a Single-Institution Prospective Study. BJU Int. 112 (2), E87\u201391. https:\/\/doi.org\/10.1111\/j.1464-410X.2012.11650.x (2013). Epub 20130116.","journal-title":"BJU Int."},{"issue":"1072","key":"48493_CR36","doi-asserted-by":"publisher","first-page":"20160787","DOI":"10.1259\/bjr.20160787","volume":"90","author":"A Sharma","year":"2017","unstructured":"Sharma, A. et al. Utility of Early Dynamic and Delayed Post-Diuretic (18)F-Fdg Pet\/Ct Suv(Max) in Predicting Tumour Grade and T-Stage of Urinary Bladder Carcinoma: Results from a Prospective Single Centre Study. Br. J. Radiol. 90 (1072), 20160787. https:\/\/doi.org\/10.1259\/bjr.20160787 (2017). Epub 20170303.","journal-title":"Br. J. Radiol."},{"issue":"6","key":"48493_CR37","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1111\/bju.12468","volume":"113","author":"GB Boustead","year":"2014","unstructured":"Boustead, G. B. et al. Grade and Pathological Characteristics of Bladder Cancer in the Uk: British Association of Urological Surgeons (Baus) Urological Tumour Registry. BJU Int. 113 (6), 924\u2013930. https:\/\/doi.org\/10.1111\/bju.12468 (2014). Epub 20140122.","journal-title":"BJU Int."},{"key":"48493_CR38","doi-asserted-by":"publisher","unstructured":"Paner, G. P. et al. International Society of Urological Pathology (Isup) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. Am J Surg Pathol 48(1):e11-e23. Epub 20230629. (2024). https:\/\/doi.org\/10.1097\/pas.0000000000002077","DOI":"10.1097\/pas.0000000000002077"},{"key":"48493_CR39","doi-asserted-by":"publisher","unstructured":"Liu, H. et al. Rapid Visualizing and Pathological Grading of Bladder Tumor Tissues by Simple Nanodiagnostics. Biomaterials 264:120434. Epub 20201005. (2021). https:\/\/doi.org\/10.1016\/j.biomaterials.2020.120434","DOI":"10.1016\/j.biomaterials.2020.120434"},{"issue":"6","key":"48493_CR40","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/j.juro.2013.11.056","volume":"191","author":"ON Gofrit","year":"2014","unstructured":"Gofrit, O. N. et al. Mixed High and Low Grade Bladder Tumors\u2013Are They Clinically High or Low Grade? J. Urol. 191 (6), 1693\u20131696. https:\/\/doi.org\/10.1016\/j.juro.2013.11.056 (2014). Epub 20131205.","journal-title":"J. Urol."},{"issue":"9","key":"48493_CR41","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1097\/00043764-199009000-00016","volume":"32","author":"EM Messing","year":"1990","unstructured":"Messing, E. M. & Vaillancourt, A. Hematuria Screening for Bladder Cancer. J. Occup. Med. 32 (9), 838\u2013845. https:\/\/doi.org\/10.1097\/00043764-199009000-00016 (1990).","journal-title":"J. Occup. Med."},{"issue":"12","key":"48493_CR42","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1007\/s00261-019-02276-w","volume":"44","author":"AL Wentland","year":"2019","unstructured":"Wentland, A. L., Desser, T. S., Troxell, M. L. & Kamaya, A. Bladder Cancer and Its Mimics: A Sonographic Pictorial Review with Ct\/Mr and Histologic Correlation. Abdom. Radiol. (NY). 44 (12), 3827\u20133842. https:\/\/doi.org\/10.1007\/s00261-019-02276-w (2019).","journal-title":"Abdom. Radiol. (NY)"},{"key":"48493_CR43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.urology.2023.03.049","volume":"178","author":"MJ Hyman","year":"2023","unstructured":"Hyman, M. J., Skolarus, T. A., Litwack, K., Meltzer, D. O. & Modi, P. K. Outcomes of Hematuria Evaluation by Advanced Practice Providers and Urologists. Urology 178, 67\u201375. https:\/\/doi.org\/10.1016\/j.urology.2023.03.049 (2023). Epub 20230516.","journal-title":"Urology"},{"key":"48493_CR44","doi-asserted-by":"publisher","unstructured":"Huang, C., Ai, X., Hu, L. & Ren, D. The Role of Nmp22 and Cstb Levels in Predicting Postoperative Recurrence of Bladder Cancer. J Immunol Res 2022:6735310. Epub 20220519. (2022). https:\/\/doi.org\/10.1155\/2022\/6735310","DOI":"10.1155\/2022\/6735310"},{"issue":"3","key":"48493_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamaoncol.2024.6160","volume":"11","author":"IG Jeong","year":"2025","unstructured":"Jeong, I. G. et al. Urinary DNA Methylation Test for Bladder Cancer Diagnosis. JAMA Oncol. 11 (3), 293\u2013299. https:\/\/doi.org\/10.1001\/jamaoncol.2024.6160 (2025).","journal-title":"JAMA Oncol."},{"issue":"3","key":"48493_CR46","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1097\/cu9.0000000000000098","volume":"16","author":"WK Al-Delaimy","year":"2022","unstructured":"Al-Delaimy, W. K., Awadalla, A., El-Assmy, A., Abol-Enein, H. & Shokeir, A. Comparison of Urinary Telomerase, Cd44, and Nmp22 Assays for Detection of Bladder Squamous Cell Carcinoma. Curr. Urol. 16 (3), 154\u2013159. https:\/\/doi.org\/10.1097\/cu9.0000000000000098 (2022). Epub 20220802.","journal-title":"Curr. Urol."},{"issue":"5","key":"48493_CR47","doi-asserted-by":"publisher","first-page":"102144","DOI":"10.1016\/j.clgc.2024.102144","volume":"22","author":"A Salari","year":"2024","unstructured":"Salari, A. et al. Prognostic Value of Nlr, Plr, Sii, and Dnlr in Urothelial Bladder Cancer Following Radical Cystectomy. Clin. Genitourin. Cancer. 22 (5), 102144. https:\/\/doi.org\/10.1016\/j.clgc.2024.102144 (2024). Epub 20240622.","journal-title":"Clin. Genitourin. Cancer"},{"issue":"5","key":"48493_CR48","doi-asserted-by":"publisher","first-page":"467","DOI":"10.56434\/j.arch.esp.urol.20227505.68","volume":"75","author":"H Chen","year":"2022","unstructured":"Chen, H. et al. The Clinicopathological and Prognostic Value of Nlr, Plr and Mlr in Non-Muscular Invasive Bladder Cancer. Arch. Esp. Urol. 75 (5), 467\u2013471. https:\/\/doi.org\/10.56434\/j.arch.esp.urol.20227505.68 (2022).","journal-title":"Arch. Esp. Urol."},{"key":"48493_CR49","doi-asserted-by":"publisher","unstructured":"Balistreri, C. R. et al. Shed Syndecans (1\u20133), Ela-32, Bdnf, Nlr, and Hs-Crp in Parkinson\u2019s Disease: Appropriate Diagnostic and Prognostic Biomarkers When Combined in a Unique Panel. Int. J. Mol. Sci. 26 (10). https:\/\/doi.org\/10.3390\/ijms26104503 (2025). Epub 20250508.","DOI":"10.3390\/ijms26104503"},{"key":"48493_CR50","doi-asserted-by":"publisher","unstructured":"Vrapcea, A. et al. Inflammatory Signatures and Biological Markers in Platelet-Rich Plasma Therapy for Hair Regrowth: A Comprehensive Narrative Analysis. Diagnostics (Basel). 15 (9). https:\/\/doi.org\/10.3390\/diagnostics15091123 (2025). Epub 20250428.","DOI":"10.3390\/diagnostics15091123"},{"key":"48493_CR51","doi-asserted-by":"publisher","first-page":"103470","DOI":"10.1016\/j.redox.2024.103470","volume":"79","author":"X Qi","year":"2025","unstructured":"Qi, X. et al. Machine Learning and Shap Value Interpretation for Predicting Comorbidity of Cardiovascular Disease and Cancer with Dietary Antioxidants. Redox Biol. 79, 103470. https:\/\/doi.org\/10.1016\/j.redox.2024.103470 (2025). Epub 20241216.","journal-title":"Redox Biol."},{"issue":"11","key":"48493_CR52","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla, A. V., Schmitt, V., Maier, C. S., Mensing, S. & Stodtmann, S. Practical Guide to Shap Analysis: Explaining Supervised Machine Learning Model Predictions in Drug Development. Clin. Transl Sci. 17 (11), e70056. https:\/\/doi.org\/10.1111\/cts.70056 (2024).","journal-title":"Clin. Transl Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48493-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:55:48Z","timestamp":1780872948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48493-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48493-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committees of Wuxi People\u2019s Hospital, Wuxi Second People\u2019s Hospital, and Tengzhou Central People\u2019s Hospital (Approval No. KY23026). As this is a retrospective study, and in accordance with local regulations, written informed consent from patients or their guardians was waived. All methods were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"17583"}}